[Response to combined therapy with plasmapheresis and high doses of immunoglobulin in Lambert-Eaton syndrome].
Díez-Tejedor
E
E
Tejada
J
J
Ramos
M J
MJ
Frank
A
A
Cruz-Martínez
A
A
Vivancos
F
F
Barreiro
P
P
D000368:Aged; D003131:Combined Modality Therapy; D006801:Humans; D007136:Immunoglobulins / Q000008:administration & dosage* / Q000627:therapeutic use*; D007275:Injections, Intravenous; D015624:Lambert-Eaton Myasthenic Syndrome / Q000150:complications / Q000188:drug therapy* / Q000628:therapy*; D008297:Male; D009069:Movement Disorders / Q000209:etiology; D010956:Plasmapheresis / Q000379:methods*; D016896:Treatment Outcome
D007136:Immunoglobulins
Respuesta de un caso de síndrome de Lambert-Eaton al tratamiento combinado con plasmaféresis y altas dosis de inmunoglobulina intravenosa.